You are here: » Timelines » Verily Life Sciences LLC

Verily Life Sciences LLC

» Timelines » Verily Life Sciences LLC

Verily Life Sciences LLC

Parent Company
Filtered by:
Verily Life Sciences LLC
15 Feb

Johnson & Johnson $3.4 billion in cash for Auris surgical robots

Johnson & Johnson announced that Ethicon Inc entered into a definitive agreement to acquire Auris Health Inc for approximately $3.4 billion in cash.
4 Dec

Low cost technology to print sensors enabling smart contact lenses

VSPARTICLE announced its low-cost technology to print nanostructured materials that will finally enable applications such as smart contact lenses to succeed. The nanotech company has developed an additive manufacturing technology that can be used for numerous applications, such as producing real-time medical sensors (glucose sensing, bio-marker sensing, etc.), as well as, accurate gas sensors.
9 Nov

Bioelectronic Medicine 2019-2029

IDTechEx Report: Dr Nadia Tsao
14 Aug

Biomedical Diagnostics at Point-of-Care 2019-2029: Technologies, Applications, Forecasts

IDTechEx Report: Dr Luyun Jiang
14 Aug

Technologies for Diabetes Management 2019-2029: Technology, Players and Forecasts

IDTechEx Report: James Hayward
2 Jul

Electronic Skin Patches 2018-2028

IDTechEx Report: James Hayward
21 May

Wearable Technology 2018-2028: Markets, Players, Forecasts

IDTechEx Report: James Hayward
26 Oct

NASCAR, JCDecaux, Galvani and Terrafugia to open the IDTechEx Show!

Opening the IDTechEx Show! in Santa Clara, Nov 15-16, are four select Cornerstone presentations which will showcase how new technologies are coming to market which solve big problems created by changing demographics and global megatrends, from mobility to healthcare to enabling the ubiquity of electronics.
13 Sep

Wearable Sensors 2018-2028: Technologies, Markets & Players

IDTechEx Report: James Hayward
8 Sep

Implantable devices to alter electrical impulses in the body

GSK has announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, to form Galvani Bioelectronics to enable the research, development and commercialisation of bioelectronic medicines.
6 Feb

How Big Pharma is betting on electronics

As the business model for commercializing new drugs becomes increasingly more difficult to sustain, the pharmaceutical industry is trying to reinvent itself. One bet is on electronic devices that could provide direct treatment of some chronic diseases. The race is on to find new materials that will be compatible for this new form of medicine.
17 Mar

Google - Verily

Dr Harry Zervos spoke to Sohyun Park, a hardware engineer with Verily, previously a division of Google X and now Alphabet's research organization that focuses on developing new technologies in life sciences.Sohyun discussed with Dr Zervos some of Verily's activities in smart contact lenses and smart glasses platform developments.